Douglas Lane & Associates’s Envision Healthcare Holdings Inc EVHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-243,135
Closed -$11.1M 226
2018
Q3
$11.1M Sell
243,135
-444,637
-65% -$20M 0.22% 96
2018
Q2
$30.3M Sell
687,772
-112,295
-14% -$4.61M 0.64% 65
2018
Q1
$30.7M Buy
800,067
+127,815
+19% +$4.78M 0.67% 67
2017
Q4
$23.2M Buy
672,252
+562,554
+513% +$19.7M 0.49% 71
2017
Q3
$4.93M Buy
109,698
+60,656
+124% +$3.23M 0.11% 106
2017
Q2
$3.07M Buy
49,042
+14,340
+41% +$826K 0.07% 123
2017
Q1
$2.13M Buy
34,702
+31,289
+917% +$2.1M 0.05% 131
2016
Q4
$216K Buy
+3,413
New +$223K 0.01% 201

Other funds holding EVHC

Douglas Lane & Associates's EVHC Position: Q4 2018 in Review

Douglas Lane & Associates sold out of Envision Healthcare Holdings Inc (EVHC) in Q4 2018, closing a stake of 243,135 shares — an estimated $11.1M sold.

Douglas Lane & Associates first reported a position in EVHC in Q4 2016 and held it in 8 quarters. The position peaked at $30.7M in Q1 2018. 4 funds tracked by Wall St. Rank hold EVHC as of Q4 2018.

  • Douglas Lane & Associates reported no remaining Envision Healthcare Holdings Inc position as of Q4 2018 after selling out during the quarter.
  • Douglas Lane & Associates sold 243,135 Envision Healthcare Holdings Inc shares in Q4 2018, an estimated $11.1M.
  • Douglas Lane & Associates first reported a position in Envision Healthcare Holdings Inc in Q4 2016 and held it in 8 quarters.
  • Douglas Lane & Associates's Envision Healthcare Holdings Inc position peaked at $30.7M in Q1 2018.
  • 4 funds tracked by Wall St. Rank held Envision Healthcare Holdings Inc as of Q4 2018.

Based on Douglas Lane & Associates's 13F filing for Q4 2018, filed 17 Jan 2019.